Hikma Pharmaceuticals PLC Cash Flow-to-Debt Ratio
Hikma Pharmaceuticals PLC cash flow-to-debt ratio. Hikma Pharmaceuticals PLC (HIK) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2025, meaning its operating cash flow of GBX161.00 Million could theoretically repay 0% of its total liabilities (GBX3.00 Billion) in one year. Check Hikma Pharmaceuticals PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hikma Pharmaceuticals PLC (2002–2024)
Cash flow-to-debt ratio of Hikma Pharmaceuticals PLC from 2002 to 2024. Historical debt coverage capacity for Hikma Pharmaceuticals PLC across 23 annual periods. Check HIK operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Hikma Pharmaceuticals PLC Cash Flow-to-Debt Ratio by Year (2002–2024)
Hikma Pharmaceuticals PLC cash flow-to-debt ratio by year from 2002 to 2024. Year-by-year debt coverage analysis for Hikma Pharmaceuticals PLC. For the full cash flow conversion analysis, see Hikma Pharmaceuticals PLC cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.20x | GBX564.00 Million | GBX2.81 Billion | ▼ -18.5% |
| 2023 | 0.25x | GBX608.00 Million | GBX2.47 Billion | ▲ +7.8% |
| 2022 | 0.23x | GBX530.00 Million | GBX2.32 Billion | ▼ -31.9% |
| 2021 | 0.33x | GBX638.00 Million | GBX1.91 Billion | ▲ +43.4% |
| 2020 | 0.23x | GBX464.00 Million | GBX1.99 Billion | ▼ -10.9% |
| 2019 | 0.26x | GBX472.00 Million | GBX1.80 Billion | ▲ +9.7% |
| 2018 | 0.24x | GBX430.00 Million | GBX1.80 Billion | ▲ +0.3% |
| 2017 | 0.24x | GBX443.00 Million | GBX1.86 Billion | ▲ +58.7% |
| 2016 | 0.15x | GBX293.00 Million | GBX1.95 Billion | ▼ -48.9% |
| 2015 | 0.29x | GBX366.00 Million | GBX1.25 Billion | ▼ -28.4% |
| 2014 | 0.41x | GBX425.00 Million | GBX1.03 Billion | ▲ +9.1% |
| 2013 | 0.38x | GBX337.00 Million | GBX895.00 Million | ▲ +82.4% |
| 2012 | 0.21x | GBX182.16 Million | GBX882.26 Million | ▲ +56.3% |
| 2011 | 0.13x | GBX102.64 Million | GBX777.01 Million | ▼ -65.2% |
| 2010 | 0.38x | GBX138.79 Million | GBX365.52 Million | ▲ +22.2% |
| 2009 | 0.31x | GBX105.52 Million | GBX339.46 Million | ▲ +92.0% |
| 2008 | 0.16x | GBX57.87 Million | GBX357.46 Million | ▲ +76.2% |
| 2007 | 0.09x | GBX43.12 Million | GBX469.38 Million | ▼ -57.6% |
| 2006 | 0.22x | GBX29.99 Million | GBX138.56 Million | ▼ -26.9% |
| 2005 | 0.30x | GBX32.71 Million | GBX110.48 Million | ▼ -8.7% |
| 2004 | 0.32x | GBX32.84 Million | GBX101.31 Million | ▲ +1.4% |
| 2003 | 0.32x | GBX18.35 Million | GBX57.39 Million | ▲ +4.3% |
| 2002 | 0.31x | GBX14.35 Million | GBX46.84 Million | — |